Danaher reports softness in its diagnostics segment due to procurement changes, coinciding with an inquiry from Bank of America analysts about bioprocessing trends.
1 report, 1 independent
Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Danaher reports softness in its diagnostics segment due to procurement changes, coinciding with an inquiry from Bank of America analysts about bioprocessing trends.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Danaher (Australia)
Nothing else this week.
-
Bank of America
American multinational banking and financial services corporation
Coverage
Newest first; wire copies grouped- StockStory5 Revealing Analyst Questions From Danaher’s Q2 Earnings Call Danaher’s second quarter results came in ahead of Wall Street’s revenue and profit expectations, with steady growth in its bioprocessing